CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN)

CUSIP: 23255M105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
4,330,313
Total 13F shares
21,236,761
Share change
+240,734
Total reported value
$18,262,273
Price per share
$0.86
Number of holders
29
Value change
+$225,673
Number of buys
5
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 23255M105?
CUSIP 23255M105 identifies CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Slate Path Capital LP
13F
Company
165%
7,157,601
$3,928,000 30 Jun 2022
13F
MFN Partners Management, LP
13F
Company
78%
3,389,215
$1,860,000 30 Jun 2022
13F
Artal Group S.A.
13F
Company
64%
2,779,122
$1,525,000 30 Jun 2022
13F
FMR LLC
13F
Company
59%
2,537,720
$1,393,000 30 Jun 2022
13F
VANGUARD GROUP INC
13F
Company
41%
1,754,153
$963,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13%
573,694
$314,000 30 Jun 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
11%
456,077
$250,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
8.3%
361,564
$198,000 30 Jun 2022
13F
TRUSTCORE FINANCIAL SERVICES, LLC
13F
Company
6.8%
292,645
$161,000 30 Jun 2022
13F
Diametric Capital, LP
13F
Company
5.6%
243,539
$134,000 30 Jun 2022
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
5.4%
231,952
$127,000 30 Jun 2022
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
2.9%
126,192
$69,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
2.7%
115,414
$63,000 30 Jun 2022
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
2.7%
115,000
$63,000 30 Jun 2022
13F
COLONY GROUP LLC
13F
Company
2.4%
102,884
$57,000 30 Jun 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
2.2%
96,700
$53,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
1.9%
80,736
$44,000 30 Jun 2022
13F
FRANKLIN RESOURCES INC
13F
Company
1.8%
77,993
$43,000 30 Jun 2022
13F
JANE STREET GROUP, LLC
13F
Company
1.3%
58,292
$32,000 30 Jun 2022
13F
TWO SIGMA SECURITIES, LLC
13F
Company
1.3%
54,638
$30,000 30 Jun 2022
13F
PRUDENTIAL FINANCIAL INC
13F
Company
1.2%
52,270
$29,000 30 Jun 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.2%
51,589
$28,000 30 Jun 2022
13F
Intrinsic Value Partners, LLC
13F
Company
1.1%
48,315
$27,000 30 Jun 2022
13F
MACKENZIE FINANCIAL CORP
13F
Company
0.94%
40,920
$22,000 30 Jun 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.74%
31,956
$18,000 30 Jun 2022
13F
Verition Fund Management LLC
13F
Company
0.46%
20,000
$11,000 30 Jun 2022
13F
GROUP ONE TRADING LLC
13F
Company
0.42%
18,368
$10,000 30 Jun 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.31%
13,569
$8,000 30 Jun 2022
13F
DAVENPORT & Co LLC
13F
Company
0.3%
13,000
$7,000 30 Jun 2022
13F
MORGAN STANLEY
13F
Company
0.12%
5,058
$3,000 30 Jun 2022
13F
SIMPLEX TRADING, LLC
13F
Company
0.08%
3,390
$1,000 30 Jun 2022
13F
High Net Worth Advisory Group LLC
13F
Company
0.02%
1,000
$1,000 30 Jun 2022
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.01%
317
$174 30 Jun 2022
13F
Andreas Busch
3/4/5
Chief Scientific Officer
class O/S missing
135,000
20 Jan 2022
Anjeza Gjino
3/4/5
Chief Financial Officer
class O/S missing
135,000
20 Jan 2022
Cheryl Gault
3/4/5
Chief Operating Officer
class O/S missing
135,000
20 Jan 2022
George H. Conrades
3/4/5
Director
class O/S missing
20,000
14 Jun 2022
Marsha Fanucci
3/4/5
Director
class O/S missing
20,000
14 Jun 2022
Michael Mendelsohn
3/4/5
Director
class O/S missing
20,000
14 Jun 2022
Ole Isacson
3/4/5
Director
class O/S missing
20,000
14 Jun 2022
Stephanie Lovell
3/4/5
Director
class O/S missing
20,000
14 Jun 2022
Kevin Churchwell
3/4/5
Director
class O/S missing
10,000
24 Jun 2021

Institutional Holders of CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) as of Q3 2022

As of 30 Sep 2022, CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,236,761 shares. The largest 10 holders included Slate Path Capital LP, FMR LLC, MFN Partners Management, LP, Artal Group S.A., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., TRUSTCORE FINANCIAL SERVICES, LLC, RENAISSANCE TECHNOLOGIES LLC, and Diametric Capital, LP. This page lists 29 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
32
Q3 2022 holders
29
Holder diff
-3
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .